chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Radiation associated pain, Somnolence, Vomiting
Clinical narrative: she cannot lay horizontal; pain in the joints in her legs; fell down twice; threw up twice; slept for 20 hours/fell asleep at the wheel/fell asleep in her car; felt incredible pain in her whole body; toes and feet felt numb; pain progressed to calves and thighs/she has pain in her hips, thighs, through her upper body; nerve damage that is escalating; nerve pain; she cannot walk; pain progressed horizontal through her midline and groin; pain progressed horizontal through her midline and groin; This spontaneous case was reported by a consumer and describes the occurrence of FALL (fell down twice), VOMITING (threw up twice), SOMNOLENCE (slept for 20 hours/fell asleep at the wheel/fell asleep in her car), PAIN (felt incredible pain in her whole body) and HYPOAESTHESIA (toes and feet felt numb) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced FALL (fell down twice), VOMITING (threw up twice), SOMNOLENCE (slept for 20 hours/fell asleep at the wheel/fell asleep in her car) and PAIN (felt incredible pain in her whole body). In April 2021, the patient experienced HYPOAESTHESIA (toes and feet felt numb), PAIN IN EXTREMITY (pain progressed to calves and thighs/she has pain in her hips, thighs, through her upper body), NEURALGIA (nerve pain), GAIT DISTURBANCE (she cannot walk) and NERVE INJURY (nerve damage that is escalating). In 2021, the patient experienced GROIN PAIN (pain progressed horizontal through her midline and groin) and RADIATION ASSOCIATED PAIN (pain progressed horizontal through her midline and groin). In July 2021, the patient experienced MOBILITY DECREASED (she cannot lay horizontal) and ARTHRALGIA (pain in the joints in her legs). On 16-Apr-2021, FALL (fell down twice) and SOMNOLENCE (slept for 20 hours/fell asleep at the wheel/fell asleep in her car) outcome was unknown, VOMITING (threw up twice) had resolved. At the time of the report, PAIN (felt incredible pain in her whole body), HYPOAESTHESIA (toes and feet felt numb), PAIN IN EXTREMITY (pain progressed to calves and thighs/she has pain in her hips, thighs, through her upper body), GROIN PAIN (pain progressed horizontal through her midline and groin), NEURALGIA (nerve pain), GAIT DISTURBANCE (she cannot walk), MOBILITY DECREASED (she cannot lay horizontal), ARTHRALGIA (pain in the joints in her legs), NERVE INJURY (nerve damage that is escalating) and RADIATION ASSOCIATED PAIN (pain progressed horizontal through her midline and groin) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis, SARS-CoV-2 test
Clinical narrative: mild disease/ cold-like symptoms; 5 of our employees tested positive for breakthrough infections/ all 5 were vaccinated with the same lot # of Moderna; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (5 of our employees tested positive for breakthrough infections/ all 5 were vaccinated with the same lot # of Moderna) and NASOPHARYNGITIS (mild disease/ cold-like symptoms) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jul-2021, the patient experienced COVID-19 (5 of our employees tested positive for breakthrough infections/ all 5 were vaccinated with the same lot # of Moderna). On an unknown date, the patient experienced NASOPHARYNGITIS (mild disease/ cold-like symptoms). At the time of the report, COVID-19 (5 of our employees tested positive for breakthrough infections/ all 5 were vaccinated with the same lot # of Moderna) and NASOPHARYNGITIS (mild disease/ cold-like symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.   This case was linked to MOD-2021-270723, MOD-2021-270623 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis, SARS-CoV-2 test
Clinical narrative: mild disease / cold-like symptoms; 5 of our employees tested positive with breakthrough infections; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (5 of our employees tested positive with breakthrough infections) and NASOPHARYNGITIS (mild disease / cold-like symptoms) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jul-2021, the patient experienced COVID-19 (5 of our employees tested positive with breakthrough infections). On an unknown date, the patient experienced NASOPHARYNGITIS (mild disease / cold-like symptoms). At the time of the report, COVID-19 (5 of our employees tested positive with breakthrough infections) and NASOPHARYNGITIS (mild disease / cold-like symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. no treatment details were reported.   This case was linked to MOD-2021-270723, MOD-2021-270620 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported. Patient has stated that she did not experienced any events regarding first dose.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Updated Reporter's information. On 03-Aug-2021: Updated patient details.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Product quality issue
Clinical narrative: mild disease / cold-like symptoms / none hospitalized; all 5 were vaccinated with the same lot # of Moderna; This spontaneous case was reported by a health care professional and describes the occurrence of NASOPHARYNGITIS (mild disease / cold-like symptoms / none hospitalized) and PRODUCT QUALITY ISSUE (all 5 were vaccinated with the same lot # of Moderna) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 012L20A) for COVID-19 vaccination.     Medical history was not provided.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced PRODUCT QUALITY ISSUE (all 5 were vaccinated with the same lot # of Moderna). On an unknown date, the patient experienced NASOPHARYNGITIS (mild disease / cold-like symptoms / none hospitalized). On 05-Feb-2021, PRODUCT QUALITY ISSUE (all 5 were vaccinated with the same lot # of Moderna) had resolved. At the time of the report, NASOPHARYNGITIS (mild disease / cold-like symptoms / none hospitalized) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided. List of concomitant medication were not given. 5 of our employees tested positive with breakthrough infections
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea
Clinical narrative: Headache; Body ache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Body ache) and NAUSEA (Nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced HEADACHE (Headache), MYALGIA (Body ache) and NAUSEA (Nausea). At the time of the report, HEADACHE (Headache), MYALGIA (Body ache) and NAUSEA (Nausea) outcome was unknown.            No relevant concomitant medications were provided.  No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: sinus infection; This spontaneous case was reported by an other health care professional and describes the occurrence of SINUSITIS (sinus infection) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02920A and 025J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Thyroid disorder NOS.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinus infection). The patient was treated with AMOXICILLIN, CLAVULANIC ACID (AUGMENTIN [AMOXICILLIN;CLAVULANIC ACID]) for Sinusitis, at an unspecified dose and frequency. At the time of the report, SINUSITIS (sinus infection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Extensive swelling of vaccinated limb, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: day 8 site size of golf ball; injection site swollen, red, and hot to touch; injection site swollen, red, and hot to touch; injection site swollen, red, and hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site swollen, red, and hot to touch), EXTENSIVE SWELLING OF VACCINATED LIMB (day 8 site size of golf ball), VACCINATION SITE SWELLING (injection site swollen, red, and hot to touch) and VACCINATION SITE ERYTHEMA (injection site swollen, red, and hot to touch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced VACCINATION SITE WARMTH (injection site swollen, red, and hot to touch), VACCINATION SITE SWELLING (injection site swollen, red, and hot to touch) and VACCINATION SITE ERYTHEMA (injection site swollen, red, and hot to touch). On 28-Jul-2021, the patient experienced EXTENSIVE SWELLING OF VACCINATED LIMB (day 8 site size of golf ball). At the time of the report, VACCINATION SITE WARMTH (injection site swollen, red, and hot to touch), EXTENSIVE SWELLING OF VACCINATED LIMB (day 8 site size of golf ball), VACCINATION SITE SWELLING (injection site swollen, red, and hot to touch) and VACCINATION SITE ERYTHEMA (injection site swollen, red, and hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. No treatment medication was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Over 36 days since 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Over 36 days since 1st dose) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Over 36 days since 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Over 36 days since 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was provided by the reporter. No treatment medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Off label use
Clinical narrative: Patient didn't receive the vaccine yet, passed more than 42 days of the time window between both doses. She was advised by her doctor to wait 12 weeks before receiving the second dose; Vaccine administered to pregnant; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of OFF LABEL USE (Patient didn't receive the vaccine yet, passed more than 42 days of the time window between both doses. She was advised by her doctor to wait 12 weeks before receiving the second dose) and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine administered to pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced OFF LABEL USE (Patient didn't receive the vaccine yet, passed more than 42 days of the time window between both doses. She was advised by her doctor to wait 12 weeks before receiving the second dose) and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine administered to pregnant). At the time of the report, OFF LABEL USE (Patient didn't receive the vaccine yet, passed more than 42 days of the time window between both doses. She was advised by her doctor to wait 12 weeks before receiving the second dose) outcome was unknown and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine administered to pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow up added on 29-Jul-2021 and updated medical history and events.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: chest pains; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jul-2021 and was forwarded to Moderna on 30-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pains). At the time of the report, CHEST PAIN (chest pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Oropharyngeal discomfort, Paranasal sinus discomfort, Vaccination complication
Clinical narrative: does not feel good at all; throat doesn't feel right; feel it in my chest and sinuses; feel it in my chest and sinuses; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (does not feel good at all), OROPHARYNGEAL DISCOMFORT (throat doesn't feel right), PARANASAL SINUS DISCOMFORT (feel it in my chest and sinuses) and CHEST DISCOMFORT (feel it in my chest and sinuses) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jul-2021, the patient experienced VACCINATION COMPLICATION (does not feel good at all), OROPHARYNGEAL DISCOMFORT (throat doesn't feel right), PARANASAL SINUS DISCOMFORT (feel it in my chest and sinuses) and CHEST DISCOMFORT (feel it in my chest and sinuses). At the time of the report, VACCINATION COMPLICATION (does not feel good at all), OROPHARYNGEAL DISCOMFORT (throat doesn't feel right), PARANASAL SINUS DISCOMFORT (feel it in my chest and sinuses) and CHEST DISCOMFORT (feel it in my chest and sinuses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Per patient her events was nothing huge but her throat did not feel right and she felt in her chest and sinuses.  it was reported the patient she never had any severe reactions to her injections.  No concomitant medication was  provided.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Sep-2021: Follow-up include non-significant information new reporter added and narrative updated. On 01-Oct-2021: Follow-up include no new information; Reporter's Comments: I am a Medical Assistant. My provider I work with has requested me to send you a decline on filling out a Moderna reactions to her injection.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Caller said something about side effects but nothing in particular was mentioned; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (caller said something about side effects but nothing in particular was mentioned) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (caller said something about side effects but nothing in particular was mentioned). At the time of the report, VACCINATION COMPLICATION (caller said something about side effects but nothing in particular was mentioned) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant treatment was provided. No treatment medication was provided. Very limited information was available for adverse event.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination complication
Clinical narrative: Suffered some side effects; Outside of recommended timeframe for second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Suffered some side effects) and PRODUCT DOSE OMISSION ISSUE (Outside of recommended timeframe for second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Suffered some side effects) and PRODUCT DOSE OMISSION ISSUE (Outside of recommended timeframe for second dose). At the time of the report, VACCINATION COMPLICATION (Suffered some side effects) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Outside of recommended timeframe for second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours; a vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours was administered to 3 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours) and EXPIRED PRODUCT ADMINISTERED (a vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours was administered to 3 patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT STORAGE ERROR (vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours) and EXPIRED PRODUCT ADMINISTERED (a vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours was administered to 3 patients). On 29-Jul-2021, PRODUCT STORAGE ERROR (vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours) and EXPIRED PRODUCT ADMINISTERED (a vial of Moderna Covid-19 Vaccine that stayed out of the refrigerator for more than 12 hours was administered to 3 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Vaccination complication
Clinical narrative: Husband had a bad affect on the first one; Husband being really tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Husband had a bad affect on the first one) and FATIGUE (Husband being really tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Husband had a bad affect on the first one) and FATIGUE (Husband being really tired). At the time of the report, VACCINATION COMPLICATION (Husband had a bad affect on the first one) and FATIGUE (Husband being really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 5 or so patiens got a those of the Moderna vaccine from a vial that was punctured for more than 12 hours.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 or so patiens got a those of the Moderna vaccine from a vial that was punctured for more than 12 hours.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (5 or so patiens got a those of the Moderna vaccine from a vial that was punctured for more than 12 hours.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (5 or so patiens got a those of the Moderna vaccine from a vial that was punctured for more than 12 hours.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitants were not provided.  The reporter calling to get some guidance on an incident where a vial that had been punctured for more than 12 hours was used to administer the Moderna vaccine to several patients. The vial was puncture and used a few days later. Patients affected are unknown but HCP states that 5 or so. HCP states they think only one vial was affected and that they are not aware of previous excursion affecting that vial.  Treatment was not given.   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Very swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Very swollen lymph nodes) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0471321A or 047B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included THEOPHYLLINE, AMLODIPINE, HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) and Flexeril for an unknown indication.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Very swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (Very swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Dizziness, Muscle spasms
Clinical narrative: dizziness; weakness; confusion; cramps; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (weakness), CONFUSIONAL STATE (confusion) and MUSCLE SPASMS (cramps) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced DIZZINESS (dizziness), ASTHENIA (weakness), CONFUSIONAL STATE (confusion) and MUSCLE SPASMS (cramps). At the time of the report, DIZZINESS (dizziness), ASTHENIA (weakness), CONFUSIONAL STATE (confusion) and MUSCLE SPASMS (cramps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: symptoms; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (symptoms) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016c21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MORPHINE SULFATE and Oxycodone 60mg for an unknown indication.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (symptoms). The patient was treated with LIDOCAINE ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Sinusitis
Clinical narrative: Sore Throat; All the typical symptoms of a sinus infection; Headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), SINUSITIS (All the typical symptoms of a sinus infection) and HEADACHE (Headache) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat), SINUSITIS (All the typical symptoms of a sinus infection) and HEADACHE (Headache). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat), SINUSITIS (All the typical symptoms of a sinus infection) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment medication was provided.   This case was linked to MOD-2021-270540 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received on 04-AUG-2021, contains no new information.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Feeding disorder, Headache, Impaired work ability, Myalgia, Vomiting
Clinical narrative: Couldn't go to work; Couldn't eat; Body ache; Threw up 2 times; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (Couldn't go to work), FEEDING DISORDER (Couldn't eat), MYALGIA (Body ache), VOMITING (Threw up 2 times) and HEADACHE (Severe headache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided by reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jul-2021, the patient experienced IMPAIRED WORK ABILITY (Couldn't go to work), FEEDING DISORDER (Couldn't eat), MYALGIA (Body ache), VOMITING (Threw up 2 times) and HEADACHE (Severe headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 2 dosage form (2 Tablets). At the time of the report, IMPAIRED WORK ABILITY (Couldn't go to work), FEEDING DISORDER (Couldn't eat), MYALGIA (Body ache) and VOMITING (Threw up 2 times) was resolving and HEADACHE (Severe headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that he had mild headache on 27-Jul-2021 which got serious on 28-Jul-2021. Patient felt better afterwards
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product dose omission issue
Clinical narrative: Missed dose; Patient received first dose in May2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose in May2021) and PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose in May2021). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose in May2021) and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and Treatment medications were reported.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Minor fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Minor fatigue) and HEADACHE (headache) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, the patient experienced FATIGUE (Minor fatigue) and HEADACHE (headache). At the time of the report, FATIGUE (Minor fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose past 36 days; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose past 36 days) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     Medical history was not provided.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose past 36 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose past 36 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant and treatment medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: the injections site of the Juvederm-like product swell/injections site get puffy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (the injections site of the Juvederm-like product swell/injections site get puffy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (the injections site of the Juvederm-like product swell/injections site get puffy). At the time of the report, VACCINATION SITE SWELLING (the injections site of the Juvederm-like product swell/injections site get puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment and concomitant information were not reported by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Product dose omission issue, Pyrexia
Clinical narrative: Only received one dose. more than 36 days since first shot; Fever; Sick for about two days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ILLNESS (Sick for about two days) and PRODUCT DOSE OMISSION ISSUE (Only received one dose. more than 36 days since first shot) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), ILLNESS (Sick for about two days) and PRODUCT DOSE OMISSION ISSUE (Only received one dose. more than 36 days since first shot). At the time of the report, PYREXIA (Fever), ILLNESS (Sick for about two days) and PRODUCT DOSE OMISSION ISSUE (Only received one dose. more than 36 days since first shot) had resolved.            No Concomitant medications were provided by the reporter. No Treatment information was reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Inflammation, Insomnia, Mass, X-ray
Clinical narrative: Inflammation in the back; Barely sleep at night; Feels like there is a knot in her back; Back pain for 3 or 4 days; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Inflammation in the back), INSOMNIA (Barely sleep at night), MASS (Feels like there is a knot in her back) and BACK PAIN (Back pain for 3 or 4 days) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 022B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Sulfonamide allergy (sulfa drugs). Concomitant products included VITAMIN B NOS, VITAMIN D NOS and VITAMINS NOS (MULTIVIT [VITAMINS NOS]) for an unknown indication.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced BACK PAIN (Back pain for 3 or 4 days). On an unknown date, the patient experienced INFLAMMATION (Inflammation in the back), INSOMNIA (Barely sleep at night) and MASS (Feels like there is a knot in her back). On 28-Jul-2021, BACK PAIN (Back pain for 3 or 4 days) had resolved. At the time of the report, INFLAMMATION (Inflammation in the back), INSOMNIA (Barely sleep at night) and MASS (Feels like there is a knot in her back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: normal (normal) Normal..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took a "muscle relaxers" and an anti-inflammatory medication for treatment.   This case was linked to MOD-2021-270722 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Head discomfort, Nausea, Pain in extremity
Clinical narrative: Cannot turn head to the left; Sore arm; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Cannot turn head to the left), PAIN IN EXTREMITY (Sore arm) and NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (Cannot turn head to the left), PAIN IN EXTREMITY (Sore arm) and NAUSEA (Nausea). At the time of the report, HEAD DISCOMFORT (Cannot turn head to the left), PAIN IN EXTREMITY (Sore arm) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.   Reporter did not allow further contact
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Inflammation, Insomnia, Mass, Pain
Clinical narrative: inflammation in the back; barely sleep at night; feels like there is a knot in her back; hurts when breathing; back pain for 3 or 4 days; This spontaneous case was reported by a patient and describes the occurrence of BACK PAIN (back pain for 3 or 4 days), INFLAMMATION (inflammation in the back), INSOMNIA (barely sleep at night), MASS (feels like there is a knot in her back) and PAIN (hurts when breathing) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy and Penicillin allergy. Concomitant products included VITAMIN B COMPLEX (VITAMIN B [VITAMIN B COMPLEX]), COLECALCIFEROL (VITAMIN D 3) and CALCIUM PANTOTHENATE, FOLIC ACID, VITAMINS NOS (MULTI-VITAMINS VITAFIT) for an unknown indication.    On 24-Apr-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced BACK PAIN (back pain for 3 or 4 days). On an unknown date, the patient experienced INFLAMMATION (inflammation in the back), INSOMNIA (barely sleep at night), MASS (feels like there is a knot in her back) and PAIN (hurts when breathing). At the time of the report, BACK PAIN (back pain for 3 or 4 days) had resolved and INFLAMMATION (inflammation in the back), INSOMNIA (barely sleep at night), MASS (feels like there is a knot in her back) and PAIN (hurts when breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis, SARS-CoV-2 test
Clinical narrative: mild, cold-like symptoms; 5 out of 368 employees who have tested positive with breakthrough COVID infection; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (5 out of 368 employees who have tested positive with breakthrough COVID infection) and NASOPHARYNGITIS (mild, cold-like symptoms) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jul-2021, the patient experienced COVID-19 (5 out of 368 employees who have tested positive with breakthrough COVID infection). On an unknown date, the patient experienced NASOPHARYNGITIS (mild, cold-like symptoms). At the time of the report, COVID-19 (5 out of 368 employees who have tested positive with breakthrough COVID infection) and NASOPHARYNGITIS (mild, cold-like symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-270623, MOD-2021-270620 (Patient Link).
Age: 33.0
Sex: U
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia oral, Musculoskeletal chest pain, Pain in extremity, Paraesthesia
Clinical narrative: pinching on the left side of my rib cage; pinching on my arm pit; tingly sensation; tip of the tongue is numb; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (pinching on the left side of my rib cage), PAIN IN EXTREMITY (pinching on my arm pit), PARAESTHESIA (tingly sensation), HYPOAESTHESIA ORAL (tip of the tongue is numb) and HEADACHE (headache) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (pinching on the left side of my rib cage), PAIN IN EXTREMITY (pinching on my arm pit), PARAESTHESIA (tingly sensation), HYPOAESTHESIA ORAL (tip of the tongue is numb) and HEADACHE (headache). At the time of the report, MUSCULOSKELETAL CHEST PAIN (pinching on the left side of my rib cage), PAIN IN EXTREMITY (pinching on my arm pit), PARAESTHESIA (tingly sensation), HYPOAESTHESIA ORAL (tip of the tongue is numb) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: received his first Moderna dose on 16/Mar/2021 came into the facility to see if he can receive his second dose now; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received his first Moderna dose on 16/Mar/2021 came into the facility to see if he can receive his second dose now) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (received his first Moderna dose on 16/Mar/2021 came into the facility to see if he can receive his second dose now). At the time of the report, PRODUCT DOSE OMISSION ISSUE (received his first Moderna dose on 16/Mar/2021 came into the facility to see if he can receive his second dose now) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.